These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1389921)

  • 1. Malignant melanoma.
    Smyth JF
    Cancer Chemother Biol Response Modif; 1992; 13():588-99. PubMed ID: 1389921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma.
    Smyth JF
    Cancer Chemother Biol Response Modif; 1990; 11():531-43. PubMed ID: 2223406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant melanoma--prognosis and actual treatment strategies with chemotherapy and biological response modifiers.
    Bergmann L
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S31-6. PubMed ID: 2697576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current aspects in the treatment of malignant melanoma].
    Barth A; Cerny T
    Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
    Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant melanoma of the skin in Denmark--epidemiology, diagnosis and treatment].
    von der Maase H; Osterlind A; Drzewiecki KT; Dahlstrøm KK; Geertsen PF; Gjedde SB; Hastrup NC; Holmberg SB; Krag C; Lock-Andersen J
    Ugeskr Laeger; 1992 Jul; 154(28):1949-53. PubMed ID: 1509557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant mucosal melanoma of the head and neck.
    Bradley PJ
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):100-4. PubMed ID: 16552267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant melanoma--diagnosis and treatment].
    Jacobsen KD; Fosså SD; Aamdal S
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3094-7. PubMed ID: 17160112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.